CFM
BHVN icon

Catalyst Funds Management’s Biohaven BHVN Stock Holding History

Catalyst Funds Management’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-18,109
Closed -$272K – 355
2025
Q3 		$272K Buy
+18,109
New +$264K 0.04% 346
2024
Q4 		– Sell
-1,400
Closed -$70K – 426
2024
Q3 		$70K Buy
+1,400
New +$54.5K 0.02% 640

Other funds holding BHVN

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RPSM
Royalty Pharma Sub-Manager New York $242M AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Catalyst Funds Management's BHVN Position: Q4 2025 in Review

Catalyst Funds Management sold out of Biohaven (BHVN) in Q4 2025, closing a stake of 18,109 shares — an estimated $272K sold.

Catalyst Funds Management first reported a position in BHVN in Q3 2024 and held it in 2 quarters. The position peaked at $272K in Q3 2025. 273 funds tracked by Wall St. Rank hold BHVN as of Q4 2025.

  • Catalyst Funds Management reported no remaining Biohaven position as of Q4 2025 after selling out during the quarter.
  • Catalyst Funds Management sold 18,109 Biohaven shares in Q4 2025, an estimated $272K.
  • Catalyst Funds Management first reported a position in Biohaven in Q3 2024 and held it in 2 quarters.
  • Catalyst Funds Management's Biohaven position peaked at $272K in Q3 2025.
  • 273 funds tracked by Wall St. Rank held Biohaven as of Q4 2025.

Based on Catalyst Funds Management's 13F filing for Q4 2025, filed 9 Feb 2026.